Abstract
Since the Collaborative Ocular Melanoma Study (COMS) reported similar mortality rates between enucleation and plaque brachytherapy for patients with medium-sized choroidal melanoma, radiation plaques have become the standard method of treatment for uveal melanoma. However, enucleation remains a valid primary treatment technique in some cases of melanoma with specific surgical indications, risks, and benefits. Today, most physicians evaluate the size and location of the tumor, the presence of extrascleral extensions, feasibility of vision retention, and patient preference when deciding between surgical options, although controversy remains regarding the best treatment course for small-and large-sized tumors. In recent years, genetic profiling has also become an important factor in deciding metastatic risk in uveal melanoma, and fine needle aspiration biopsy is now an important step in assessing melanoma prognosis.
Original language | English (US) |
---|---|
Title of host publication | Uveal Melanoma |
Subtitle of host publication | Biology and Management |
Publisher | Springer International Publishing |
Pages | 69-88 |
Number of pages | 20 |
ISBN (Electronic) | 9783030781170 |
ISBN (Print) | 9783030781163 |
DOIs | |
State | Published - Jan 1 2021 |
Keywords
- Choroidal melanoma
- Enucleation
- Fine needle aspiration biopsy
- Plaque brachytherapy
- Radiation therapy
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology